Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Stryker Corp (SYK) reports over 10% organic sales growth and outlines strategic acquisitions amidst challenges in its Q4 2024 ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

FY25 Outlook: Sirius XM expects revenue of $8.500 billion versus the consensus of $8.594 billion. It also projected an adjusted EBITDA of $2.60 billion and expects a free cash flow of $1.15 billion.

Truist raised the firm’s price target on Stryker (SYK) to $413 from $409 and keeps a Hold rating on the shares. The company remains a top-tier ...

Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...